Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany.
about
Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Real-world effectiveness of br ...... he United Kingdom and Germany.
@en
Real-world effectiveness of br ...... he United Kingdom and Germany.
@nl
type
label
Real-world effectiveness of br ...... he United Kingdom and Germany.
@en
Real-world effectiveness of br ...... he United Kingdom and Germany.
@nl
prefLabel
Real-world effectiveness of br ...... he United Kingdom and Germany.
@en
Real-world effectiveness of br ...... he United Kingdom and Germany.
@nl
P2093
P2860
P1433
P1476
Real-world effectiveness of br ...... he United Kingdom and Germany.
@en
P2093
Brian Seal
Courtney Johnson
Cynthia Macahilig
Erin A Zagadailov
Mehul R Dalal
Paul J Bröckelmann
Shelby Corman
Viktor Chirikov
P2860
P356
10.1080/10428194.2017.1382698
P577
2017-10-18T00:00:00Z